• Sulfaphenazole: Precision CYP2C9 Inhibitor for Translational

  2026-07-13

  Sulfaphenazole stands out as a selective CYP2C9 inhibitor, enabling robust workflows in drug metabolism, oxidative stress, and antimicrobial research. Its unique dual utility in cellular assays and animal models, backed by low cytotoxicity, positions it as a trusted tool for vascular, pharmacokinetic, and anti-tuberculosis studies.

• Synthetic Lethality via WRN Depletion in MSI Colorectal Canc

  2026-07-13

  The referenced study uncovers how Werner (WRN) helicase depletion induces selective apoptosis in mismatch repair-deficient (MSI) colorectal cancer via the p53/PUMA pathway. These mechanistic insights clarify the synthetic lethality of WRN inhibition in p53-wildtype MSI tumors, supporting targeted therapeutic strategies.

• Distinct Vascular Impacts of JAK Inhibitors in Endothelial I

  2026-07-12

  This article reviews a recent study comparing the vascular effects of approved JAK inhibitors—including tofacitinib citrate—on endothelial cells exposed to inflammatory cytokines. The findings reveal critical differences in cytokine modulation, adhesion molecule expression, and endothelial apoptosis among inhibitors, with practical implications for immune regulation and cardiovascular research.

• Neticonazole Hydrochloride: Dual-Action Imidazole Antifungal

  2026-07-10

  Neticonazole Hydrochloride stands out not only as a first-line topical antifungal for cutaneous candidiasis but also as an innovative tool in colorectal cancer research. Its ability to inhibit fungal cell membrane synthesis and modulate tumor exosome pathways enables cross-domain applications in both mycology and oncology.

• EPZ-6438 in Translational Oncology: Synergy, Resistance, and

  2026-07-09

  Explore how EPZ-6438, a leading EZH2 inhibitor, uniquely enables resistance-overcoming strategies and synergistic therapies in translational epigenetic cancer research. This article offers practical protocol guidance, comparative insight, and a deeper look at combinatorial assay design.

• Injectable Hemostatic Adhesive Combats Non-Compressible Hemo

  2026-07-09

  This study presents an injectable, dual-network GelMA/QCS/Ca2+ adhesive that achieves rapid hemostasis and robust antibacterial activity for non-compressible wounds. The work demonstrates significant advances over existing wound dressings, offering new perspectives for emergency trauma care and biomaterials design.

• Adipose-Neural Axis in Epicardial Adipose Tissue-Driven Arrh

  2026-07-08

  Fan et al. (2024) establish a stem cell-based coculture model revealing that the adipose-neural axis, specifically the leptin–NPY/Y1R pathway, is a central driver of epicardial adipose tissue (EAT)-related cardiac arrhythmias. Their findings highlight new molecular intervention targets, offering mechanistic clarity for future translational and cardiovascular research.

• Berberine Hydrochloride: Translational Leverage in Metabolic

  2026-07-08

  This article explores Berberine Hydrochloride’s mechanistic and translational potential, spotlighting its AMPK-mediated pathways, relevance in metabolic and cancer models, and strategic guidance for optimizing experimental design. Drawing from recent mitochondrial protection research and advanced workflows, we position APExBIO’s Berberine Hydrochloride at the forefront of innovative disease modeling.

• DMG-PEG2000-NH2: Enabling Next-Gen Lipid Nanoparticle Platfo

  2026-07-07

  Explore the advanced utility of DMG-PEG2000-NH2 as a versatile NH2-PEG derivative for lipid nanoparticle (LNP) and liposomal drug delivery. This article uniquely bridges molecular mechanism, protocol parameters, and recent antibacterial research to guide optimal application in biomedical workflows.

• MLN2238: Advanced Proteasome β5 Inhibition for Redox Biology

  2026-07-07

  Explore the unique role of MLN2238 as a proteasome β5 subunit inhibitor, with new insights into its application in redox signaling and proteostasis. This article offers a deeper look at protocol nuances and cross-disease research opportunities, grounded in robust scientific evidence.

• Redefining Precision: Prestained Protein Marker for Ribosome

  2026-07-06

  Explore how the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) transforms quantitative ribosome biology and protein analysis. Gain advanced insights into structural discoveries, protocol refinement, and assay design using this innovative molecular weight standard.

• CLCC1 Identified as Host Fusion Factor in Herpesvirus Nuclea

  2026-07-06

  A recent study uncovers CLCC1 as a crucial host factor mediating membrane fusion during herpesvirus nuclear egress, a key step previously lacking a defined cellular component. This finding clarifies a fundamental mechanism of herpesvirus replication and suggests new research directions for antiviral strategies targeting host-virus interactions.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Evide

  2026-07-05

  Chen et al. (2021) identify moesin (MSN) as a mechanistically relevant and quantifiable biomarker of endothelial injury during sepsis. Their integrated clinical, animal, and in vitro evidence links MSN to disease severity and offers new directions for endothelial dysfunction research.

• T7 RNA Polymerase: Optimized RNA Synthesis for Research Work

  2026-07-04

  T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, enables high-yield, sequence-specific in vitro transcription from linearized plasmid templates and PCR products. This article details streamlined protocols, advanced applications from RNA vaccine production to RNAi research, and expert troubleshooting tips to maximize experimental success.

• Leucomycin (Kitasamycin): Resistance, MICs & Translational R

  2026-07-03

  Explore the advanced biological and resistance dynamics of Leucomycin (kitasamycin), a macrolide antibiotic, with a focus on clinically relevant MICs, resistance mechanisms, and translational inhibition in research. This article uniquely bridges molecular action with assay design and resistance profiling.

16314 records 1/1088 page Next 12345 下5页 Last page